2019 Vaccine Guide & Insert - 30

TRAVEL-CHOLERA
Travel-Cholera
What is Cholera?
Cholera is an acute, diarrheal illness caused by infection of the intestine with the toxigenic
bacterium Vibrio cholerae serogroup O1 or O139. An estimated 2.9 million cases and 95,000
deaths occur each year around the world. The infection is often mild or without symptoms, but can
sometimes be severe. Approximately one in 10 (10%) infected persons will have severe disease
characterized by profuse watery diarrhea, vomiting, and leg cramps. In these people, rapid loss of
body fluids leads to dehydration and shock. Without treatment, death can occur within hours.

Vaxchora™
Cholera Vaccine, Live, Oral
(135-7837) .......................................................3/box
CPT® Code: 90625†.

What are the recommendations for use of the new oral cholera vaccine?
CVD 103-HgR (Vaxchora, PaxVax) cholera vaccine was approved by the Food and Drug Administration
in June 2016. ACIP recommendations for Vaxchora were published in May 2017 and are
available at www.cdc.gov/mmwr/volumes/66/wr/pdfs/mm6618a6.pdf. ACIP recommends
vaccination for adults 18 through 64 years old traveling to areas of active cholera transmission.
An area of active cholera transmission is defined as a province, state, or other administrative
subdivision within a country with endemic or epidemic cholera caused by toxigenic V. cholerae
O1 and includes areas with cholera activity within the last 1 year that are prone to recurrence of
cholera epidemics; it does not include areas where rare sporadic cases have been reported. No
country or territory currently requires vaccination against cholera as a condition for entry.
In addition to vaccination, all travelers to cholera-affected areas should follow safe food and water
precautions and proper sanitation and personal hygiene measures as primary prevention strategies
against cholera infection. Travelers who develop severe diarrhea should promptly seek medical
attention for rehydration therapy.

Cholera is an acute,
diarrheal illness
caused by infection
of the intestine with
the toxigenic bacterium
Vibrio cholerae
serogroup O1 or
O139. An estimated
2.9 million cases and
95,000 deaths occur
each year around
the world.

Sources: https://www.cdc.gov/cholera/general/index.html
http://www.immunize.org/askexperts/travel-vaccines.asp
INDICATIONS AND USAGE
Vaxchora™ is a vaccine indicated for active immunization against disease caused by Vibrio
cholerae serogroup O1 in adults 18 through 64 years of age traveling to cholera‐affected countries.
CPT Information
Administration CPT Code without
physician counseling

90471, 90472, 90473 or 90474

Administration CPT Code with
physician counseling

90460 or 90461

VAXCHORA

90625

For informational purposes only. Source: ReimbursementCodes.com and/or www.cms.gov. Customer is responsible for verification of billing/coding in accordance with applicable specific circumstances.
See manufacturer package insert for full prescribing information.
†

To Order: 1.800.P.SCHEIN (1.800.772.4346) 8am-8:30pm, et

To Fax: 1.800.329.9109 24 Hrs

19MS4037

http://www.cdc.gov/mmwr/volumes/66/wr/pdfs/mm6618a6.pdf http://www.henryschein.com/redirect.aspx?did=medical&returnurl=/us-en/Shopping/ProductDetails.aspx%3Fproductid%3D1357837%26CatalogName%3DMEDICAL%26utm_source%3DMedical%26utm_medium%3DNxtbook%26utm_campaign%3Dvaccine-guide-2019%26utm_term%3D1357837 https://www.cdc.gov/cholera/general/index.html http://www.immunize.org/askexperts/travel-vaccines.asp http://www.ReimbursementCodes.com http://www.cms.gov

2019 Vaccine Guide & Insert

Table of Contents for the Digital Edition of 2019 Vaccine Guide & Insert